Maleimide-DOTA: A Versatile Bifunctional Chelator for Radiopharmaceutical Development and Bioconjugation

Unlock precision in bioconjugation and radiopharmaceutical development with our advanced Maleimide-DOTA reagent.

Get a Quote & Sample

Key Advantages

Selective Thiol Conjugation

The maleimide functional group ensures highly selective reactions with thiol groups, a fundamental aspect of effective protein and peptide labeling for various research applications.

Efficient Metal Chelation

The DOTA component is renowned for its strong affinity and rapid kinetic stability in chelating a wide range of metal ions, critical for radiolabeling in medical imaging and therapy.

Versatile Application in ADCs

As a key intermediate, Maleimide-DOTA plays a crucial role in the synthesis of antibody-drug conjugates, bridging the gap between therapeutic payloads and targeting antibodies to improve cancer treatment efficacy.

Key Applications

Radiopharmaceutical Development

Maleimide-DOTA is instrumental in creating novel radiopharmaceuticals by enabling the conjugation of chelating agents to targeting biomolecules for diagnostic and therapeutic purposes.

Antibody-Drug Conjugates (ADCs)

It serves as a vital linker in the synthesis of ADCs, facilitating the precise attachment of potent cytotoxic drugs to antibodies for targeted cancer therapy.

Bioconjugation Strategies

Researchers utilize Maleimide-DOTA for various bioconjugation applications, including the labeling of proteins, peptides, and other biomolecules for advanced research and diagnostics.

Medical Imaging

The DOTA moiety's ability to chelate medically relevant radioisotopes makes Maleimide-DOTA essential for developing imaging agents used in PET and SPECT scans.